A molecularly integrated grade for meningioma.
Saved in:
| Title: | A molecularly integrated grade for meningioma. |
|---|---|
| Authors: | Driver J; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Hoffman SE; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Harvard-MIT Program in Health Science Technology, MD-PhD Program, Harvard Medical School, Boston, Massachusetts, USA., Tavakol S; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Woodward E; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Maury EA; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Harvard-MIT Program in Health Science Technology, MD-PhD Program, Harvard Medical School, Boston, Massachusetts, USA.; Bioinformatics and Integrative Genomics Program, Harvard Medical School, Boston, Massachusetts, USA., Bhave V; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Greenwald NF; Cancer Biology Program, Stanford University School of Medicine, Stanford, California, USA., Nassiri F; Department of Neurosurgery, University of Toronto, Toronto, Ontario, Canada., Aldape K; National Cancer Institute, Bethesda, Maryland, USA., Zadeh G; Department of Neurosurgery, University of Toronto, Toronto, Ontario, Canada., Choudhury A; Departments of Radiation Oncology and Neurological Surgery, University of California San Francisco, San Francisco, California, USA., Vasudevan HN; Departments of Radiation Oncology and Neurological Surgery, University of California San Francisco, San Francisco, California, USA., Magill ST; Departments of Radiation Oncology and Neurological Surgery, University of California San Francisco, San Francisco, California, USA., Raleigh DR; Departments of Radiation Oncology and Neurological Surgery, University of California San Francisco, San Francisco, California, USA., Abedalthagafi M; King Fahad Medical City and King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia., Aizer AA; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Alexander BM; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ligon KL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Al-Mefty O; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ligon AH; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Dubuc AM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Beroukhim R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Claus EB; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Yale School of Public Health, New Haven, Connecticut, USA., Dunn IF; Department of Neurosurgery, Oklahoma University Medical Center, Oklahoma City, Oklahoma, USA., Santagata S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. |
| Source: | Neuro-oncology [Neuro Oncol] 2022 May 04; Vol. 24 (5), pp. 796-808. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noab213 |
